News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Becton, Dickinson and Company (BDX) Introduces Specialized Syringe For Eli Lilly (LLY)'s Highly Concentrated Insulin



11/15/2016 7:28:51 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Becton, Dickinson and Company (BD) has launched a new syringe designed specifically for diabetic patients taking Humulin R U-500, concentrated insulin developed and manufactured by Eli Lilly. By using a specialized syringe, patients and clinicians can avoid the dosing errors associated with traditional insulin syringes.

Some diabetic patients become resistant to insulin therapy and require higher doses — 200 units per day — to manage their disease correctly. Eli Lilly’s Humulin R U-500 contains five times more insulin per milliliter than traditional U-100 insulin, and has been available since 1994.

Read at News Release


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES